Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.31.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.31.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.31.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.31.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.31.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.31.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used